| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |